BACKGROUND: The alanine to valine mutation at codon 4 (A4V) of SOD1 causes a rapidly progressive dominant form of amyotrophic lateral sclerosis (ALS) with exclusively lower motor neuron disease and is responsible for 50% of SOD1 mutations associated with familial ALS in North America. This mutation is rare in Europe. The authors investigated the origin (geographic and time) of the A4V mutation. METHODS: Several cohorts were genotyped: North American patients with confirmed A4V mutation (n = 54), Swedish (n = 3) and Italian (n = 6) A4V patients, patients with ALS with SOD1 non-A4V mutations (n = 66) and patients with sporadic ALS (n = 96), healthy white (n = 96), African American (n = 17), Chinese (n = 53), Amerindian (n = 11), and Hispanic (n = 12) subjects. High-throughput SNP genotyping was performed using Taqman assay in 384-well format. A novel biallelic CA repeat in exon 5 of SOD1, tightly linked to A4V, was genotyped on sequencing gels. Association statistics were estimated using Haploview. p Values less than 0.05 were considered significant. Age of A4V was estimated using a novel method based on r(2) degeneration with genetic distance and a Bayesian method incorporated in DMLE+. RESULTS: A single haplotype of 10 polymorphisms across a 5.86-cM region was associated with A4V (p = 3.0e-11) when white controls were used, suggesting a founder effect. The strength of association of this haplotype progressively decreased when African American, Chinese, Hispanic, and Amerindian subjects were used as controls. The associated European haplotype was different from the North American haplotype, indicating two founder effects for A4V (Amerindian and European). The estimated age of A4V with the r(2) degeneration method was 458 +/- 59 years (range 398-569) and in agreement with the Bayesian method (554-734 years with 80-90% posterior probability). CONCLUSIONS: North American SOD1 alanine to valine mutation at codon 4 descended from two founders (Amerindian and European) 400-500 years ago.
BACKGROUND: The alanine to valine mutation at codon 4 (A4V) of SOD1 causes a rapidly progressive dominant form of amyotrophic lateral sclerosis (ALS) with exclusively lower motor neuron disease and is responsible for 50% of SOD1 mutations associated with familial ALS in North America. This mutation is rare in Europe. The authors investigated the origin (geographic and time) of the A4V mutation. METHODS: Several cohorts were genotyped: North American patients with confirmed A4V mutation (n = 54), Swedish (n = 3) and Italian (n = 6) A4Vpatients, patients with ALS with SOD1 non-A4V mutations (n = 66) and patients with sporadic ALS (n = 96), healthy white (n = 96), African American (n = 17), Chinese (n = 53), Amerindian (n = 11), and Hispanic (n = 12) subjects. High-throughput SNP genotyping was performed using Taqman assay in 384-well format. A novel biallelic CA repeat in exon 5 of SOD1, tightly linked to A4V, was genotyped on sequencing gels. Association statistics were estimated using Haploview. p Values less than 0.05 were considered significant. Age of A4V was estimated using a novel method based on r(2) degeneration with genetic distance and a Bayesian method incorporated in DMLE+. RESULTS: A single haplotype of 10 polymorphisms across a 5.86-cM region was associated with A4V (p = 3.0e-11) when white controls were used, suggesting a founder effect. The strength of association of this haplotype progressively decreased when African American, Chinese, Hispanic, and Amerindian subjects were used as controls. The associated European haplotype was different from the North American haplotype, indicating two founder effects for A4V (Amerindian and European). The estimated age of A4V with the r(2) degeneration method was 458 +/- 59 years (range 398-569) and in agreement with the Bayesian method (554-734 years with 80-90% posterior probability). CONCLUSIONS: North American SOD1alanine to valine mutation at codon 4 descended from two founders (Amerindian and European) 400-500 years ago.
Authors: Han-Xiang Deng; Yong Shi; Yoshiaki Furukawa; Hong Zhai; Ronggen Fu; Erdong Liu; George H Gorrie; Mohammad S Khan; Wu-Yen Hung; Eileen H Bigio; Thomas Lukas; Mauro C Dal Canto; Thomas V O'Halloran; Teepu Siddique Journal: Proc Natl Acad Sci U S A Date: 2006-04-24 Impact factor: 11.205
Authors: T Siddique; D A Figlewicz; M A Pericak-Vance; J L Haines; G Rouleau; A J Jeffers; P Sapp; W Y Hung; J Bebout; D McKenna-Yasek Journal: N Engl J Med Date: 1991-05-16 Impact factor: 91.245
Authors: H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos Journal: Science Date: 1993-08-20 Impact factor: 47.728
Authors: Edor Kabashi; Paul N Valdmanis; Patrick Dion; Dan Spiegelman; Brendan J McConkey; Christine Vande Velde; Jean-Pierre Bouchard; Lucette Lacomblez; Ksenia Pochigaeva; Francois Salachas; Pierre-Francois Pradat; William Camu; Vincent Meininger; Nicolas Dupre; Guy A Rouleau Journal: Nat Genet Date: 2008-03-30 Impact factor: 38.330
Authors: A Al-Chalabi; P M Andersen; B Chioza; C Shaw; P C Sham; W Robberecht; G Matthijs; W Camu; S L Marklund; L Forsgren; G Rouleau; N G Laing; P V Hurse; T Siddique; P N Leigh; J F Powell Journal: Hum Mol Genet Date: 1998-12 Impact factor: 6.150
Authors: Vivianna M Van Deerlin; James B Leverenz; Lynn M Bekris; Thomas D Bird; Wuxing Yuan; Lauren B Elman; Dana Clay; Elisabeth McCarty Wood; Alice S Chen-Plotkin; Maria Martinez-Lage; Ellen Steinbart; Leo McCluskey; Murray Grossman; Manuela Neumann; I-Lin Wu; Wei-Shiung Yang; Robert Kalb; Douglas R Galasko; Thomas J Montine; John Q Trojanowski; Virginia M-Y Lee; Gerard D Schellenberg; Chang-En Yu Journal: Lancet Neurol Date: 2008-04-07 Impact factor: 44.182
Authors: Jemeen Sreedharan; Ian P Blair; Vineeta B Tripathi; Xun Hu; Caroline Vance; Boris Rogelj; Steven Ackerley; Jennifer C Durnall; Kelly L Williams; Emanuele Buratti; Francisco Baralle; Jacqueline de Belleroche; J Douglas Mitchell; P Nigel Leigh; Ammar Al-Chalabi; Christopher C Miller; Garth Nicholson; Christopher E Shaw Journal: Science Date: 2008-02-28 Impact factor: 47.728
Authors: Melissa M Haulcomb; Nichole A Mesnard-Hoaglin; Richard J Batka; Rena M Meadows; Whitney M Miller; Kathryn P Mcmillan; Todd J Brown; Virginia M Sanders; Kathryn J Jones Journal: J Comp Neurol Date: 2015-06-22 Impact factor: 3.215
Authors: Melissa M Haulcomb; Nichole A Mesnard; Richard J Batka; Thomas D Alexander; Virginia M Sanders; Kathryn J Jones Journal: J Comp Neurol Date: 2014-07-01 Impact factor: 3.215
Authors: Ehab H Sarsour; Maneesh G Kumar; Leena Chaudhuri; Amanda L Kalen; Prabhat C Goswami Journal: Antioxid Redox Signal Date: 2009-12 Impact factor: 8.401